Bringing together unsurpassed education, innovation, and more

“Our meeting brings together unsurpassed education, innovation, advocacy, partnership with industry, mentorship, friendship, and more—all in 4 days,” said Sumit “Sam” Garg, MD, Chief Medical Editor. Dr. Garg shares what he is looking forward to at the ASCRS Annual Meeting and previews the articles in the issue.

Comments Off on Bringing together unsurpassed education, innovation, and more

Essential in-person education

Cornea Editor Julie Schallhorn, MD, discusses the importance of the in-person education that physicians will find at the ASCRS Annual Meeting and previews the articles in the Cornea section of the issue.

Comments Off on Essential in-person education

ASCRS Consensus Statement on VUITY

In August, the Prescribing Information for VUITY (pilocarpine) was updated following a voluntary submission by Allergan to the FDA. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of Vuity.

Comments Off on ASCRS Consensus Statement on VUITY

A candid conversation about VUITY

With recent case reports showing rare but serious adverse effects with the use of Vuity (pilocarpine, Allergan), EyeWorld spoke with Dagny Zhu, MD, to gain additional insights and perspectives. She commented on the adverse effects, her recommendations for counseling and prescribing, and an off-label use she has found for the product.

Comments Off on A candid conversation about VUITY